107 related articles for article (PubMed ID: 8740972)
41. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13.
Jinquan T; Frydenberg J; Mukaida N; Bonde J; Larsen CG; Matsushima K; Thestrup-Pedersen K
J Immunol; 1995 Dec; 155(11):5359-68. PubMed ID: 7594551
[TBL] [Abstract][Full Text] [Related]
42. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
[TBL] [Abstract][Full Text] [Related]
43. IL-8 derivatives with a reduced potential to form homodimers are fully active in vitro and in vivo.
Horcher M; Rot A; Aschauer H; Besemer J
Cytokine; 1998 Jan; 10(1):1-12. PubMed ID: 9505139
[TBL] [Abstract][Full Text] [Related]
44. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions.
Richardson RM; DuBose RA; Ali H; Tomhave ED; Haribabu B; Snyderman R
Biochemistry; 1995 Oct; 34(43):14193-201. PubMed ID: 7578017
[TBL] [Abstract][Full Text] [Related]
45. Two distinct cytokines released from a human aminoacyl-tRNA synthetase.
Wakasugi K; Schimmel P
Science; 1999 Apr; 284(5411):147-51. PubMed ID: 10102815
[TBL] [Abstract][Full Text] [Related]
46. The molecular basis of selectivity between CC and CXC chemokines: the possibility of chemokine antagonists as anti-inflammatory agents.
Wells TN; Lusti-Narasimhan M; Chung CW; Cooke R; Power CA; Peitsch MC; Proudfoot AE
Ann N Y Acad Sci; 1996 Oct; 796():245-56. PubMed ID: 8906232
[No Abstract] [Full Text] [Related]
47. Heterologous desensitization of IL-8-mediated chemotaxis in human neutrophils by a cell-binding fragment of fibronectin.
Stanton KJ; Frewin MB; Gudewicz PW
J Leukoc Biol; 1999 Apr; 65(4):515-22. PubMed ID: 10204581
[TBL] [Abstract][Full Text] [Related]
48. G-protein coupled receptor-mediated activation of PI 3-kinase in neutrophils.
Thelen M; Didichenko SA
Ann N Y Acad Sci; 1997 Dec; 832():368-82. PubMed ID: 9704065
[TBL] [Abstract][Full Text] [Related]
49. Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide.
Olejniczak ET; Zhou MM; Fesik SW
Biochemistry; 1997 Apr; 36(14):4118-24. PubMed ID: 9100005
[TBL] [Abstract][Full Text] [Related]
50. Unidirectional heterologous receptor desensitization between both the fMLP and C5a receptor and the IL-8 receptor.
Blackwood RA; Hartiala KT; Kwoh EE; Transue AT; Brower RC
J Leukoc Biol; 1996 Jul; 60(1):88-93. PubMed ID: 8699129
[TBL] [Abstract][Full Text] [Related]
51. 1H NMR solution structure of an active monomeric interleukin-8.
Rajarathnam K; Clark-Lewis I; Sykes BD
Biochemistry; 1995 Oct; 34(40):12983-90. PubMed ID: 7548056
[TBL] [Abstract][Full Text] [Related]
52. Intestinal intraepithelial lymphocytes have a promiscuous interleukin-8 receptor.
Roberts AI; Bilenker M; Ebert EC
Gut; 1997 Mar; 40(3):333-8. PubMed ID: 9135521
[TBL] [Abstract][Full Text] [Related]
53. Role of interleukin-8 in neutrophil signaling.
Zeilhofer HU; Schorr W
Curr Opin Hematol; 2000 May; 7(3):178-82. PubMed ID: 10786656
[TBL] [Abstract][Full Text] [Related]
54. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
[TBL] [Abstract][Full Text] [Related]
55. The dynamics of interleukin-8 and its interaction with human CXC receptor I peptide.
Kendrick AA; Holliday MJ; Isern NG; Zhang F; Camilloni C; Huynh C; Vendruscolo M; Armstrong G; Eisenmesser EZ
Protein Sci; 2014 Apr; 23(4):464-80. PubMed ID: 24442768
[TBL] [Abstract][Full Text] [Related]
56. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
57. Identification of a soluble interleukin-8 inhibitor in the supernatant of polymorphonuclear leukocytes.
Kemény L; Szolnoky G; Kenderessy AS; Gyulai R; Kiss M; Michel G; Nagy K; Ruzicka T; Dobozy A
Immunol Lett; 1998 Nov; 64(1):23-9. PubMed ID: 9865598
[TBL] [Abstract][Full Text] [Related]
58. A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8.
Nourshargh S; Perkins JA; Showell HJ; Matsushima K; Williams TJ; Collins PD
J Immunol; 1992 Jan; 148(1):106-11. PubMed ID: 1727857
[TBL] [Abstract][Full Text] [Related]
59. Structural model of human IL-13 defines the spatial interactions with the IL-13Ralpha/IL-4Ralpha receptor.
Zuegg J; Webb DC; Foster PS; Casarotto MG
Immunol Cell Biol; 2001 Aug; 79(4):332-9. PubMed ID: 11488979
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-8-derived peptide has antibacterial activity.
Björstad A; Fu H; Karlsson A; Dahlgren C; Bylund J
Antimicrob Agents Chemother; 2005 Sep; 49(9):3889-95. PubMed ID: 16127067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
